2022
Benefits of weight loss of 10% or more in patients with overweight or obesity: A review
Tahrani AA, Morton J. Benefits of weight loss of 10% or more in patients with overweight or obesity: A review. Obesity 2022, 30: 802-840. PMID: 35333446, DOI: 10.1002/oby.23371.Peer-Reviewed Original ResearchConceptsObesity-related complicationsModest weight lossWeight lossBariatric surgeryLarge weight lossReduced cancer riskWeight-related complicationsCardiovascular risk factorsHealth-related qualityWeight management programType 2 diabetesGreater weight lossMain treatment targetsCost-effective interventionLifestyle modificationLifestyle interventionSevere obesityKnee osteoarthritisSleep apneaRisk factorsCancer riskGlucose metabolismPatientsOverweightTreatment targets
2020
Effect of JumpstartMD, a Commercial Low‐Calorie Low‐Carbohydrate Physician‐Supervised Weight Loss Program, on 22,407 Adults
Bourke S, Morton JM, Williams P. Effect of JumpstartMD, a Commercial Low‐Calorie Low‐Carbohydrate Physician‐Supervised Weight Loss Program, on 22,407 Adults. Journal Of Obesity 2020, 2020: 8026016. PMID: 32318289, PMCID: PMC7157789, DOI: 10.1155/2020/8026016.Peer-Reviewed Original ResearchConceptsWeight loss programGreater weight lossWeight lossLoss programWeekly appointmentsCommercial weight loss programEffective weight lossPharmacologic treatmentLow carbohydrate foodsMeal replacementReplacement dietLast observationCompletersMajor determinantWomenDietLonger enrollmentAppointmentsPatientsCoach meetingsMonths
2017
Comparative effectiveness of primary bariatric operations in the United States
Sudan R, Maciejewski ML, Wilk AR, Nguyen NT, Ponce J, Morton JM. Comparative effectiveness of primary bariatric operations in the United States. Surgery For Obesity And Related Diseases 2017, 13: 826-834. PMID: 28236529, DOI: 10.1016/j.soard.2017.01.021.Peer-Reviewed Original ResearchConceptsBPD/DSPrimary bariatric operationsBariatric surgery centerBariatric operationsAdverse eventsSurgery centersBody mass index unitWeight lossCo-morbidity resolutionMore adverse eventsMultiple surgical centersSerious adverse eventsType 2 diabetesGreater weight lossLarge multisite cohortCurrent bariatric operationsT2D resolutionComorbidity resolutionBaseline characteristicsGastric bypassDuodenal switchSurgical centersInverse probability weightingMultisite cohortOdds ratio
2016
Effect of Vagal Nerve Blockade on Moderate Obesity with an Obesity-Related Comorbid Condition: the ReCharge Study
Morton JM, Shah SN, Wolfe BM, Apovian CM, Miller CJ, Tweden KS, Billington CJ, Shikora SA. Effect of Vagal Nerve Blockade on Moderate Obesity with an Obesity-Related Comorbid Condition: the ReCharge Study. Obesity Surgery 2016, 26: 983-989. PMID: 27048437, PMCID: PMC4831996, DOI: 10.1007/s11695-016-2143-y.Peer-Reviewed Original ResearchConceptsObesity-related comorbid conditionsBody mass indexModerate obesityComorbid conditionsPercentage excess weight lossWeight lossImplant site painVagal nerve blockadeCommon adverse eventsExcess weight lossObesity-related comorbiditiesWeight management counselingType 2 diabetesGreater weight lossSite painAdverse eventsBlockade therapyPrespecified subgroupsSevere obesitySham deviceMass indexNerve blockadeSleep apneaSafety profileClinical trials